Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


23.08.2021

1 Am J Respir Crit Care Med
1 Antimicrob Agents Chemother
5 Clin Infect Dis
1 Eur Respir J
1 J Immunol
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. GAUSI K, Ignatius EH, Sun X, Kim S, et al
    A Semi-Mechanistic Model of the Bactericidal Activity of High-Dose Isoniazid Against Multi-Drug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.
    Am J Respir Crit Care Med. 2021 Aug 17. doi: 10.1164/rccm.202103-0534.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  2. GUO S, Wang B, Fu L, Chen X, et al
    In vitro and in vivo activity of oxazolidinone candidate OTB-658 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Aug 16:AAC0097421. doi: 10.1128/AAC.00974.
    PubMed         Abstract available


    Clin Infect Dis

  3. FRITSCHI N, Wind A, Hammer J, Ritz N, et al
    Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study.
    Clin Infect Dis. 2021 Aug 19. pii: 6354867. doi: 10.1093.
    PubMed         Abstract available

  4. LEWIS JM, Mphasa M, Keyala L, Banda R, et al
    A longitudinal observational study of aetiology and long-term outcomes of sepsis in Malawi revealing the key role of disseminated tuberculosis.
    Clin Infect Dis. 2021 Aug 18. pii: 6354427. doi: 10.1093.
    PubMed         Abstract available

  5. BURKE RM, Gupta Wright A
    Diagnosing Tuberculosis in People With Advanced Human Immunodeficiency Virus: More Is Needed.
    Clin Infect Dis. 2021;73:e878-e879.
    PubMed        

  6. MATOGA MM, Bisson GP, Gupta A, Miyahara S, et al
    Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy.
    Clin Infect Dis. 2021;73:e870-e877.
    PubMed         Abstract available

  7. KENDALL MA, Lalloo U, Fletcher CV, Wu X, et al
    Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
    Clin Infect Dis. 2021;73:706-715.
    PubMed         Abstract available


    Eur Respir J

  8. LINH NN, Viney K, Gegia M, Falzon D, et al
    World Health Organization treatment outcome definitions for tuberculosis: 2021 update.
    Eur Respir J. 2021;58.
    PubMed        


    J Immunol

  9. GILPIN TE, Walter FR, Herbath M, Sandor M, et al
    Mycobacterium bovis Bacillus Calmette-Guerin-Infected Dendritic Cells Induce TNF-alpha-Dependent Cell Cluster Formation That Promotes Bacterial Dissemination through an In Vitro Model of the Blood-Brain Barrier.
    J Immunol. 2021;207:1065-1077.
    PubMed         Abstract available


    PLoS One

  10. FOREMAN HC, Frank A, Stedman TT
    Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors.
    PLoS One. 2021;16:e0256079.
    PubMed         Abstract available

  11. SCHRAMM B, Nganaboy RC, Uwiragiye P, Mukeba D, et al
    Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children.
    PLoS One. 2021;16:e0256717.
    PubMed         Abstract available

  12. KHAN IA, Nayak B, Markandey M, Bajaj A, et al
    Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis.
    PLoS One. 2021;16:e0256098.
    PubMed         Abstract available

  13. NATHAVITHARANA RR, van der Westhuizen A, van der Westhuizen HM, Mishra H, et al
    "If I've got latent TB, I would like to get rid of it": Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment.
    PLoS One. 2021;16:e0254211.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  14. WHITWORTH LJ, Troll R, Pagan AJ, Roca FJ, et al
    Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: